PathAI provides artificial intelligence and digital pathology solutions designed to improve operational efficiency in pathology laboratories. The company's offerings centre on AISight, a cloud-native platform for managing digital pathology images in laboratory workflows and clinical operations, alongside precision pathology solutions that combine computational and medical expertise to develop and validate AI-based diagnostic models.
The company has trained and validated its models using more than 32.5 million annotations drawn from a network of over 450 pathologists. This dataset supports the development of tools intended for anatomic pathology, biopharma services, and clinical development, with applications spanning drug development, diagnostics, and clinical research. PathAI maintains a substantial library of archived pathology data and operates both proprietary and crowd-sourced components of its pathologist network.
The company works with life sciences organisations, academic researchers, and healthcare systems across multiple continents. Its stated focus is on accelerating drug development and improving diagnostic confidence through precision medicine approaches.
